Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Transkriptioner
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Pressmeddelande

Embla Medical hf.: Embla Medical hf: Conference call details for Q4/FY 2025

Embla Medical

Reykjavik, Iceland/Copenhagen, Denmark, 9 January 2026. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q4/FY 2025 Report on February 3, 2026, at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 7:00 GMT / 3:00am EST.

The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English.

Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors

To participate in the telephone conference, please use the dial-in details provided below:

DK: +45 78 76 84 90

SE: +46 31-311 50 03

UK: +44 20 3769 6819

US: +1 646 787 0157

Participant access code: 274982

The webcast will be available through following link:  Embla Medical Q4 2025 webcast

Financial calendar and events 2026

January 8, 2026            SEB Nordic Seminar, Copenhagen

February 3, 2026          Interim Report Q4 2025 & 2025 Annual Report

February 3, 2026          Q4/FY 2025 HCA Capital virtual presentation and Q&A

February 3, 2026          Q4/FY 2025 Investor Road Show, Copenhagen (Nordea)

February 4, 2026          Q4/FY 2025 Investor Road Show, Stockholm (Nordea) and Paris (ABG)

February 5, 2026          Q4/FY 2025 Investor Road Show, London (Berenberg) and Zürich (Berenberg)

February 6, 2026          Q4/FY 2025 Investor Road Show, Reykjavik (Embla HQ)

February 10, 2026        Aktiespararna Company Event,  Falkenberg Sweden

March 10, 2026            2026 Annual General Meeting

March 11, 2026             DNB Carnegie Healthcare Conference, Stockholm

March 26 2026              DNB BackBay Nordic-American Healthcare Conference, New York City

April 28, 2026                Interim Report Q1 2026

July 21, 2026                Interim Report Q2 2026

October 20, 2026          Interim Report Q3 2026

February 2, 2027           Interim Report Q4 2026/Annual Report

If you wish to receive Embla Medical press releases by e-mail, please register here

For further information please contact

Klaus Sindahl

Head of Investor Relations

M: +45 5363 0134

E: ksindahl@emblamedical.com

About Embla Medical

Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people`s mobility by providing prosthetics, neuro orthotics, bracing and patient care through global network of Oorthotic and& Pprosthetic (O&P) patient care clinics.facilities. Embla Medical is committed to sustainable business practices and is renowned for positively impacting people`s health and well-being. www.emblamedical.com

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.